Nautilus Biotechnology, Inc. NAUT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.64M | -14.47M | -14.70M | -13.78M | -13.57M |
| Total Depreciation and Amortization | 1.30M | 1.28M | 1.48M | 1.59M | 1.62M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.31M | 1.17M | 1.29M | 1.34M | 1.19M |
| Change in Net Operating Assets | -261.00K | -1.71M | -1.17M | -1.52M | -269.00K |
| Cash from Operations | -13.28M | -13.73M | -13.10M | -12.38M | -11.03M |
| Capital Expenditure | -1.45M | -454.00K | -510.00K | -244.00K | -418.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.88M | 12.48M | 14.74M | 1.03M | 870.00K |
| Cash from Investing | 10.44M | 12.02M | 14.23M | 787.00K | 452.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.00K | 244.00K | 1.11M | 101.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.00K | 244.00K | 1.11M | 101.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.82M | -1.46M | 2.24M | -11.49M | -10.58M |